Disability and determinants of gait performance in tropical spastic paraparesis/HTLV-I associated myelopathy (HAM/TSP)

Spinal Cord

Volumn 45, Issue 1, 2007, Pages 64-68

  Franzoi, A C ^a,b,d   Araujo A Q C ^a,c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Brazilian Beneficent Association of Rehabilitation (ABBR)   (Brazil)

^c Funda??o Oswaldo Cruz   (Brazil)

^d NONE   (Brazil)

Author keywords

Disability; HTLV I; Myelopathy

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISABILITY; FEMALE; GAIT; HUMAN; HUMAN EXPERIMENT; HUMAN T CELL LEUKEMIA VIRUS 1; LOW BACK PAIN; MALE; MOBILIZATION; MUSCLE STRENGTH; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; WALKING AID; WHEELCHAIR;

ACTIVITIES OF DAILY LIVING; ADULT; BRAZIL; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; GAIT; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARAPARESIS, TROPICAL SPASTIC;

EID: 33846041351     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sj.sc.3101919     Document Type: Article

References (33)

1. Castro-Costa CM, Carton H, Goubau P, Figueiredo EG, Giffoni SD. Tropical spastic paraparesis in the tropics and Brazil. A historical analysis. Arq Neuropsiquiatr 1994; 52: 106-109.
2. Gessain A et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407-410.
3. Osame M et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1: 1031-1032.
4. Roman GC, Osame M. Identity of HTLV-I-associated tropical spastic paraparesis ant HTLV-I-associated myelopathy (letter). Lancet 1988; 1: 651.
5. Gessain A, Mahieux R. Un virus appelé HTLV-1. Aspects épidémiologiques. Presse Med 2000; 29: 2233-2239.
6. Araujo A, Sheeby N, Takahashi H, Hall W. Concomitant infections with human immunodeficiency virus type 1 and human t-lymphotropic virus types 1 and 2. In: Brogden KA, Guthmiller JM (eds). Polimicrobial Diseases 1st edn. ASM Press: Washington, DC 2002, pp 75-97.
7. Araujo AQ-C, Andrade Filho AS, Castro-Costa CM, Menna-Barreto M, Almeida SM. HTLV-I associated myelopathy/tropical spastic paraparesis in Brasil: a nationwide survey. HAM/TSP Brasilian Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19: 536-541.
8. Milagres AC, Jorge ML, Marchiori PE, Segurado AA. Human T cell lymphotropic virus tipe 1-associated myelopathy in Sao Paulo, Brazil. Epidemiologic and clinical features of a university hospital cohort. Neuroepidemiology 2002; 21: 153-158.
9. Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Blattner W (ed). Human Retrovirology: HTLV 1st edn. Raven Press: New York 1990, pp 191-197.
10. Hoffer MM, Feiwell E, Perry R, Perry J Bonnett C. Functional ambulation in patients with myelomeningocele. J Bone Joint Surg Am 1973; 55: 137-148.
11. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practioner 1964; 192: 540-542.
12. Kendall HO, Kendall FP, Wadsworth GE. Músculos. Provas e Funções. 2nd edn. Editora Manole: São Paulo 1980.
13. Daniels L, Worthingham C. Provas de Função Muscular. Técnicas manuais de exploração 3rd edn. Editora Interamericana: Rio de Janeiro 1972.
14. Waters RL, Yakura JS, Adkins R, Barnes G. Determinants of gait performance following spinal cord injury. Arch Phys Med Rehabil 1989; 70: 811-818.
15. Maynard FM et al. International standards for neurological and functional classification of spinal cord injury. American Spinal Injury Association. Spinal Cord 1997; 35: 266-274.
16. Guide for the Uniform Data Set for Medical Rehabilitation (Adult FIM). State University of New York at Buffalo: Buffalo 1993.
17. Bucher B, Poupard JA, Vernant JC, DeFreitas EC. Tropical neuromyelopathies and retroviruses: a review. Rev Infect Dis 1990; 12: 890-899.
18. Roman GC. The neuroepidemiology of tropical spastic paraparesis. Ann Neurol 1988; 23: S113-S120.
19. Montgomery RD. HTLV-1 and tropical spastic paraparesis. 1. Clinical features, pathology and epidemiology. Trans R Soc Trop Med Hyg 1989; 83: 724-728.
20. Nakagawa M et al. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1995; 1: 50-61.
21. Araujo A Q-C, Andrade Filho AS, Castro-Costa CM, Menna-Barreto M, Almeida SM. HTLV-I associated myelopathy/tropical spastic paraparesis in Brazil: a nationwide survey. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19: 536-541.
22. Cartier L, Gormaz A. Subcortical dementia in HTLV-I tropical spastic paraparesis. Study of 43 cases. Rev Med Chil 1999; 127: 444-450.
23. Crozier KS, Ling Ling Chen BS, Graziani V, Zorn G, Herbison G, Ditunno JF. Spinal cord injury: prognosis for ambulation based on quadriceps recovery. Paraplegia 1992; 30: 762-767.
24. Barbeau H, Ladoucer M, Norman KE, Pepin A, Leroux A. Walking after spinal cord injury: evaluation, treatment, and functional recovery. Arch Phys Med Rehabil 1999; 80: 225-235.
25. Hussey RW, Stauffer ES. Spinal cord injury: requirements for ambulation. Arch Phys Med Rehabil 1973; 54: 544-547.
26. Perry J. Gait Analysis. Normal and Pathological Function 1st edn. SLACK Inc.: Thorofare 1992.
27. Waters RL, Yakura JS, Adkins RH. Gait performance after spinal cord injury. Clin Orthop 1993; 288: 87-96.
28. Roman GC, Roman LN, Spencer PS, Schoenberg BS. Tropical spastic paraparesis: a neuroepidemiological study in Colombia. Ann Neurol 1985; 17: 361-365.
29. Katz RT. Management of spasticity. In: Braddom RL, Dumitru D, Johnson EW, Matthews D, Sinaki M (eds). Physical Medicine Rehabilitation 1st edn. WB Saunders Company: Philadelphia 1996, pp 580-592.
30. Greve J. Fisiopatologia e avaliação clínica da espasticidade. Rev Hosp Clin Fac Med S Paulo 1994; 49: 141-144.
31. Douglas AJ, Walsh EG, Wright GW, Edmond P. Muscle tone around the human knee in paraplegia. Q J Esp Physiol 1989; 74: 897-905.
32. Dietz V, Wirz M, Jensen L. Locomotion in patients with spinal cord injuries. Phys Ther 1997; 77: 508-516.
33. Franzoi AC, Araújo AQ. Disability profile of patients with HTLV-I associated myelopathy/tropical spastic paraparesis using The Functional Independence Measure (FIM). Spinal Cord 2005; 43: 236-240.